These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31401413)

  • 1. The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma.
    Sun G; Zhang X; Liu Z; Zhu S; Shen P; Zhang H; Zhang M; Chen N; Zhao J; Chen J; Liu J; Dai J; Wang Z; Zhu X; Wang Y; Zeng H
    Neoplasia; 2019 Sep; 21(9):921-931. PubMed ID: 31401413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses.
    Tian L; Luo N; Zhu X; Chung BH; Garvey WT; Fu Y
    Atherosclerosis; 2012 Mar; 221(1):66-75. PubMed ID: 22227293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor.
    Xia Y; Liu L; Xiong Y; Bai Q; Wang J; Xi W; Qu Y; Xu J; Guo J
    BMC Cancer; 2017 Jan; 17(1):70. PubMed ID: 28114889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression.
    Kleinmann N; Duivenvoorden WC; Hopmans SN; Beatty LK; Qiao S; Gallino D; Lhotak S; Daya D; Paschos A; Austin RC; Pinthus JH
    Clin Exp Metastasis; 2014 Feb; 31(2):169-83. PubMed ID: 24096711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.
    D'Costa NM; Lowerison MR; Raven PA; Tan Z; Roberts ME; Shrestha R; Urban MW; Monjaras-Avila CU; Oo HZ; Hurtado-Coll A; Chavez-Munoz C; So AI
    J Exp Clin Cancer Res; 2020 Feb; 39(1):33. PubMed ID: 32041631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma.
    Ruan H; Li S; Bao L; Zhang X
    Oncogene; 2020 Sep; 39(38):6113-6128. PubMed ID: 32814829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin receptor expression in human malignant tissues.
    Chou SH; Tseleni-Balafouta S; Moon HS; Chamberland JP; Liu X; Kavantzas N; Mantzoros CS
    Horm Cancer; 2010 Jun; 1(3):136-45. PubMed ID: 21761356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
    Zhu Q; Zhong AL; Hu H; Zhao JJ; Weng DS; Tang Y; Pan QZ; Zhou ZQ; Song MJ; Yang JY; He JY; Liu Y; Li M; Hu WM; Yang CP; Xiang T; Chen MY; Ma G; Guo L; Xia JC
    J Hematol Oncol; 2020 Jan; 13(1):2. PubMed ID: 31900208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-κB/MMP-9 signaling.
    Chen S; Liu W; Wang K; Fan Y; Chen J; Ma J; Wang X; He D; Zeng J; Li L
    PLoS One; 2017; 12(3):e0173725. PubMed ID: 28288190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma.
    Zhu Y; Xu L; Zhang J; Xu W; Liu Y; Yin H; Lv T; An H; Liu L; He H; Zhang H; Liu J; Xu J; Lin Z
    Cancer Sci; 2013 Jun; 104(6):663-71. PubMed ID: 23433103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor.
    Cai W; Wang Z; Cai B; Yuan Y; Kong W; Zhang J; Chen Y; Liu Q; Huang Y; Huang J; Xue W
    Int J Clin Oncol; 2020 Feb; 25(2):338-346. PubMed ID: 31720994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma.
    Cheng SP; Liu CL; Hsu YC; Chang YC; Huang SY; Lee JJ
    Cell Biochem Biophys; 2013 Mar; 65(2):203-10. PubMed ID: 22907586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX9 was involved in TKIs resistance in renal cell carcinoma via Raf/MEK/ERK signaling pathway.
    Li XL; Chen XQ; Zhang MN; Chen N; Nie L; Xu M; Gong J; Shen PF; Su ZZ; Weng X; Tan JY; Zhao T; Zeng H; Zhou Q
    Int J Clin Exp Pathol; 2015; 8(4):3871-81. PubMed ID: 26097571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
    Cai W; Yuan YC; Li MY; Kong W; Dong BJ; Chen YH; Zhang J; Xue W; Huang YR; Zhou LX; Huang JW
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):384-389. PubMed ID: 29860767
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of adiponectin and its receptors is altered in epithelial ovarian tumors and ascites-derived ovarian cancer cell lines.
    Tiwari A; Ocon-Grove OM; Hadley JA; Giles JR; Johnson PA; Ramachandran R
    Int J Gynecol Cancer; 2015 Mar; 25(3):399-406. PubMed ID: 25700032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 induces drug resistance in renal cell carcinoma.
    Ishibashi K; Koguchi T; Matsuoka K; Onagi A; Tanji R; Takinami-Honda R; Hoshi S; Onoda M; Kurimura Y; Hata J; Sato Y; Kataoka M; Ogawsa S; Haga N; Kojima Y
    Fukushima J Med Sci; 2018 Dec; 64(3):103-110. PubMed ID: 30369518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma.
    Sekino Y; Takemoto K; Murata D; Babasaki T; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Taniyama D; Shigeta M; Kuraoka K; Mita K; Kaneko M; Sentani K; Oue N; Teishima J
    Anticancer Res; 2021 Oct; 41(10):4875-4883. PubMed ID: 34593435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway.
    Lin Y; Yang Z; Xu A; Dong P; Huang Y; Liu H; Li F; Wang H; Xu Q; Wang Y; Sun D; Zou Y; Zou X; Wang Y; Zhang D; Liu H; Wu X; Zhang M; Fu Y; Cai Z; Liu C; Wu S
    Sci Rep; 2015 Mar; 5():8997. PubMed ID: 25757764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway.
    Cui XB; Wang C; Li L; Fan D; Zhou Y; Wu D; Cui QH; Fu FY; Wu LL
    Cardiovasc Res; 2012 Jan; 93(1):69-78. PubMed ID: 22012952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
    Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
    Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.